Materialise Reports Third Quarter 2016 Results
Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services,
today announced its financial results for the third quarter ended September 30, 2016.
Highlights – Third Quarter 2016
- Total revenue increased 11.0% from the third quarter of 2015 to 28,736 kEUR, with increases in all
three business segments.
- Materialise Software revenue up 21.1% from the third quarter of 2015.
- Adjusted EBITDA was 2,833 kEUR compared to 1,175 kEUR for the third quarter of 2015
- Total deferred revenue from annual software sales and maintenance contracts increased 2,347 kEUR from
11,816 kEUR for the third quarter of 2015 to 14,163 kEUR for the third quarter of 2016.
Executive Chairman Peter Leys commented, “Despite continued soft market conditions, Materialise again delivered double-digit
revenue growth and an increase in Adjusted EBITDA. Led by gains in our Materialise Software segment, where we realized strong gains
in new licenses and recurring license revenue, total revenue rose 11.0% from the third quarter of 2015. Adjusted EBITDA increased
from 1,175 kEUR to 2,833 kEUR. While many market participants continue to await the introduction of the next generation of
printers, Materialise took a significant step forward with the launch of our partnership with HOYA Vision Care to transform the
eyewear industry. Together, we are enabling the world’s first vision-centric 3D-tailored eyewear, using 3D printing technology to
provide individualized lens and frame design backed by an end-to-end digital supply chain. Our groundbreaking partnership with an
industry leader is a prime example of the way we continue to position Materialise as the software and services backbone of the 3D
printing industry. We are developing additional meaningful partnerships that should serve us well when the industry resumes its
growth and continue to fine-tune our operations to enhance efficiency.”
Third Quarter 2016 Results
Total revenue for the third quarter of 2016 increased by 11.0% to 28,736 kEUR compared to 25,883 kEUR for the third quarter
of 2015, with gains in all three of our segments, particularly Materialise Software. Adjusted EBITDA increased from 1,175
kEUR to 2,833 kEUR, as a result of the combination of continued revenue growth, an improvement in our gross margins and a modest
increase in operational expenses. The Adjusted EBITDA margin (Adjusted EBITDA divided by total revenue) in the third quarter was
9.9% compared to 4.5% in the third quarter of last year.
Revenue from our Materialise Software segment, which offers a proprietary software backbone that enables and enhances the
functionality of 3D printers and 3D printing operations worldwide, increased by 21.1% to 7,632 kEUR for the third quarter of 2016
from 6,303 kEUR for the same quarter last year, driven by the growth of OEM sales and recurring license revenue. Segment EBITDA
rose to 2,814 kEUR from 2,157 kEUR while the segment EBITDA margin was 36.9% compared to 34.2% in the prior-year period.
Revenue from our Materialise Medical segment, which offers a unique platform consisting of medical planning and design software,
clinical engineering services and patient specific devices, increased by 4.5% to 9,537 kEUR for the third quarter of 2016 compared
to 9,123 kEUR for the same period in 2015. The increase was driven by direct sales of our complex surgery solutions, which
increased by 28.0% from the same period in 2015. Sales from our collaborated medical device business, and our medical software
sales decreased by 2.2% and 1.9%, respectively, compared to the same quarter in 2015. Segment EBITDA was approximately flat at 754
kEUR compared 763 kEUR while the segment EBITDA margin decreased to 7.9% from 8.4% in the third quarter of 2015.
Revenue from our Materialise Manufacturing segment, which offers an integrated suite of 3D printing and engineering services to
industrial and commercial customers, increased 10.6% to 11,567 kEUR for the third quarter of 2016 from 10,457 kEUR for the third
quarter of 2015, as a result of increased end part manufacturing. Segment EBITDA rose to 1,723 kEUR from 799 kEUR, including 460
kEUR related to the updated accounting valuation of resin materials stock as result of steady efficiency improvements. The segment
EBITDA margin increased to 14.9% from 7.6% for the 2015 quarter. Excluding our growth businesses i.materialise and RapidFit, the
segment EBITDA margin for the third quarter was 21.8% compared to 17.1% for the same quarter of the prior year.
Gross profit was 16,937 kEUR, or 58.9% of total revenue, for the third quarter of 2016 compared to 14,702 kEUR, or 56.8% of
total revenue, for the third quarter of 2015. The increase was primarily a result of the improvement in the gross margin of
Materialise Manufacturing.
Research and development (“R&D”), sales and marketing (“S&M”) and general and administrative (“G&A”) expenses
increased, in the aggregate, by 4.6% to 17,974 kEUR for the third quarter of 2016 from 17,179 kEUR for the third quarter of 2015.
R&D expenses decreased slightly from 4,566 kEUR to 4,389 kEUR while S&M expenses declined slightly from 8,657 kEUR to 8,299
kEUR. G&A expenses increased from 3,956 kEUR to 5,286 kEUR. As in the first two quarters of 2016, these changes compared to
last year primarily reflected the managerial structure and support we have implemented within our S&M and R&D groups to
support their significant growth since our initial public offering (“IPO”). A number of employees with mixed roles within these
groups have evolved into more managerial/administrative roles, and their cost as well as certain other expenses are now categorized
into G&A.
Net other operating income decreased by 274 kEUR to 1,369 kEUR, compared to 1,643 kEUR for the third quarter of 2015. Net other
operating income consists primarily of withholding tax exemptions for qualifying researchers, development grants, partial funding
of R&D projects and currency exchange results on purchase and sales transactions.
Net financial result was (124) kEUR, compared to 151 kEUR for the prior-year period, reflecting smaller variances in the
currency exchange rates, primarily on the portion of the company’s IPO proceeds held in U.S. dollars versus the euro.
Net loss for the third quarter of 2016 was (52) kEUR, compared to a net loss of (1,104) kEUR for the same period in the prior
year. The improvement of 1,052 kEUR reflected an increase of 1,166 kEUR in operating profit, a decrease of 275 kEUR in the
financial result, and an improvement of 105 kEUR in income tax income. Total comprehensive loss for the third quarter of 2016,
which reflects exchange differences on translation of foreign operations, was (511) kEUR compared to (1,821) kEUR for the same
period in the prior year.
At September 30, 2016, we had cash and equivalents of 50,490 kEUR compared to 50,726 kEUR at December 31, 2015. Cash flow from
operating activities in the third quarter of 2016 was (1,466) kEUR, compared to 268 kEUR in the same period last year.
Net shareholders’ equity at September 30, 2016 was 78,098 kEUR, compared to 82,955 kEUR at December 31, 2015.
Facility Expansion
In August 2016, to position Materialise for long-term growth, the company closed on two debt financings to expand our production
facilities in Poland and our corporate facilities in Belgium. Materialise plans to invest approximately 17,000 kEUR in capital
expenditures over the next nine months. The terms of the financings provide for 15-year term loans at fixed interest rates below
1.5%, with amortization deferred until 2023 and 2019 for the Belgium and Poland loans, respectively.
2016 Guidance
The company’s outlook for fiscal year 2016 remains within our previous guidance range for revenues and Adjusted EBITDA, which
called for consolidated revenue between 115,000 - 120,000 kEUR and Adjusted EBITDA between 7,000 - 9,000 kEUR. We expect a
seasonally active fourth quarter for our Materialise Software segment, but given the transition stage of our industry, which is
awaiting a new generation of systems with increased value propositions, we expect that revenues for fiscal year 2016 will be at the
lower end of the guidance range. We expect deferred revenue from annual licenses and maintenance to increase by an amount between
2,000 and 3,000 kEUR from 13,136 kEUR as of December 31, 2015.
Non-IFRS Measures
Materialise uses EBITDA and Adjusted EBITDA as supplemental financial measures of its financial performance. EBITDA is
calculated as net profit plus income taxes, financial expenses (less financial income), shares of loss in a joint venture and
depreciation and amortization. Adjusted EBITDA is determined by adding non-cash stock-based compensation expenses to EBITDA.
Management believes these non-IFRS measures to be important measures as they exclude the effects of items which primarily reflect
the impact of long-term investment and financing decisions, rather than the performance of the company's day-to-day operations. As
compared to net profit, these measures are limited in that they do not reflect the periodic costs of certain capitalized tangible
and intangible assets used in generating revenues in the company's business, or the charges associated with impairments. Management
evaluates such items through other financial measures such as capital expenditures and cash flow provided by operating activities.
The company believes that these measurements are useful to measure a company's ability to grow or as a valuation measurement. The
company's calculation of EBITDA and Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.
EBITDA and Adjusted EBITDA should not be considered as alternatives to net profit or any other performance measure derived in
accordance with IFRS. The company's presentation of EBITDA and Adjusted EBITDA should not be construed to imply that its future
results will be unaffected by unusual or non-recurring items.
Exchange Rate
This press release contains translations of certain euro amounts into U.S. dollars at specified rates solely for the convenience
of readers. Unless otherwise noted, all translations from euros to U.S. dollars in this press release were made at a rate of EUR
1.00 to USD 1.1161, the 12:00 noon ET buying rate of the Federal Reserve Bank of New York for the euro on September 30, 2016.
Conference Call and Webcast
Materialise will hold a conference call and simultaneous webcast to discuss its financial results for the third quarter of 2016
today, November 9, 2016, at 8:30 a.m. ET/14:30 CET. Company participants on the call will include Wilfried Vancraen, Founder and
Chief Executive Officer; Peter Leys, Executive Chairman; and Johan Albrecht, Chief Financial Officer. A question-and-answer session
will follow management’s remarks.
To access the conference call, please dial 844-469-2530 (U.S.) or 765-507-2679 (international), passcode #2102394. The
conference call will also be broadcast live over the Internet with an accompanying slide presentation, which can be accessed on the
company’s website at http://investors.materialise.com.
A replay of the conference call will be available via telephone beginning approximately one hour after the call ends through
Thursday, November 10, 2016. U.S. participants can access the replay by dialing 855-859-2056 and international participants can
dial 404-537-3406. The access code for the replay is #2102394. A webcast of the conference call and slide presentation will be
archived on the company's website for one year.
About Materialise
Materialise incorporates more than 25 years of 3D printing experience into a range of software solutions and 3D printing
services, which Materialise seeks to form the backbone of the 3D printing industry. Materialise’s open and flexible solutions
enable players in a wide variety of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, to
build innovative 3D printing applications that aim to make the world a better and healthier place. Headquartered in Belgium, with
branches worldwide, Materialise combines one of the largest groups of software developers in the industry with one of the largest
3D printing facilities in the world. For additional information, please visit: www.materialise.com.
Cautionary Statement on Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions,
beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both
financial and business, including statements concerning, among other things, current estimates of fiscal 2016 revenues, deferred
revenue from annual licenses and maintenance and Adjusted EBITDA, results of operations, cash needs, capital expenditures,
expenses, financial condition, liquidity, prospects, growth and strategies, and the trends and competition that may affect the
markets, industry or us. Such statements are subject to known and unknown uncertainties and risks. When used in this press release,
the words “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “will,” “may,” “could,” “might,”
“aim,” “should,” and variations of such words or similar expressions are intended to identify forward-looking statements. These
forward-looking statements are based upon the expectations of management under current assumptions at the time of this press
release. These expectations, beliefs and projections are expressed in good faith and the company believes there is a reasonable
basis for them. However, the company cannot offer any assurance that our expectations, beliefs and projections will actually be
achieved. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive
dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer
or shorter timelines than anticipated. We caution you that forward-looking statements are not guarantees of future performance and
involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. All of the
forward-looking statements are subject to risks and uncertainties that may cause the company's actual results to differ materially
from our expectations, including risk factors described in the company's annual report on Form 20-F filed with the U.S. Securities
and Exchange Commission on April 28, 2016. There are a number of risks and uncertainties that could cause the company's actual
results to differ materially from the forward-looking statements contained in this press release.
The company is providing this information as of the date of this press release and does not undertake any obligation to update
any forward-looking statements contained in this press release as a result of new information, future events or otherwise, unless
it has obligations under the federal securities laws to update and disclose material developments related to previously disclosed
information.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated income statements (Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended
30 September
|
|
For the nine month
period ended 30
September
|
(in thousands, except EPS) |
|
|
2016 |
|
|
2016 |
|
|
2015 |
|
|
2016 |
|
|
2015 |
|
|
|
U.S.$ |
|
|
euros |
|
|
euros |
|
|
euros |
|
|
euros |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
|
|
32,072 |
|
|
28,736 |
|
|
25,883 |
|
|
83,000 |
|
|
74,003 |
Cost of sales |
|
|
(13,169) |
|
|
(11,799) |
|
|
(11,181) |
|
|
(33,848) |
|
|
(31,507) |
Gross profit |
|
|
18,903 |
|
|
16,937 |
|
|
14,702 |
|
|
49,152 |
|
|
42,496 |
|
|
|
|
|
|
58.9% |
|
|
56.8% |
|
|
59.2% |
|
|
57.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development expenses |
|
|
(4,899) |
|
|
(4,389) |
|
|
(4,566) |
|
|
(13,521) |
|
|
(13,444) |
Sales and marketing expenses |
|
|
(9,263) |
|
|
(8,299) |
|
|
(8,657) |
|
|
(26,647) |
|
|
(27,492) |
General and administrative expenses |
|
|
(5,900) |
|
|
(5,286) |
|
|
(3,956) |
|
|
(15,225) |
|
|
(11,278) |
Other operating income |
|
|
1,528 |
|
|
1,369 |
|
|
1,643 |
|
|
4,433 |
|
|
4,897 |
Other operating expenses |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
|
Operating profit |
|
|
369 |
|
|
332 |
|
|
(834) |
|
|
(1,808) |
|
|
(4,821) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial expenses |
|
|
(203) |
|
|
(182) |
|
|
(373) |
|
|
(1,688) |
|
|
(2,108) |
Financial income |
|
|
65 |
|
|
58 |
|
|
524 |
|
|
1,037 |
|
|
2,793 |
Share in loss of joint venture |
|
|
(77) |
|
|
(69) |
|
|
(125) |
|
|
(368) |
|
|
(248) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profit (loss) before taxes |
|
|
154 |
|
|
139 |
|
|
(808) |
|
|
(2,827) |
|
|
(4,384) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes |
|
|
(213) |
|
|
(191) |
|
|
(296) |
|
|
(812) |
|
|
(621) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net profit (loss) |
|
|
(59) |
|
|
(52) |
|
|
(1,104) |
|
|
(3,639) |
|
|
(5,005) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net profit (loss) attributable to: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The owners of the parent |
|
|
(59) |
|
|
(52) |
|
|
(1,104) |
|
|
(3,639) |
|
|
(4,952) |
Non-controlling interest |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(53) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share attributable to |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ordinary owners of the parent |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
(0.00) |
|
|
(0.00) |
|
|
(0.02) |
|
|
(0.08) |
|
|
(0.10) |
Diluted |
|
|
(0.00) |
|
|
(0.00) |
|
|
(0.02) |
|
|
(0.08) |
|
|
(0.10) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average basic |
|
|
47,325 |
|
|
47,325 |
|
|
47,227 |
|
|
47,325 |
|
|
47,208 |
Weighted average with effect dilution |
|
|
47,325 |
|
|
47,325 |
|
|
47,227 |
|
|
47,325 |
|
|
47,208 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated statements of comprehensive income (Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands, except EPS) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended
30 September
|
|
For the nine month
period ended 30
September
|
|
|
|
2016 |
|
|
2016 |
|
|
2015 |
|
|
2016 |
|
|
2015 |
|
|
|
U.S.$ |
|
|
euros |
|
|
euros |
|
|
euros |
|
|
euros |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net profit (loss) for the period |
|
|
(59) |
|
|
(52) |
|
|
(1,104) |
|
|
(3,639) |
|
|
(5,005) |
Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange differences on translation of foreign operations |
|
|
(512) |
|
|
(459) |
|
|
(717) |
|
|
(1,898) |
|
|
759 |
Other comprehensive income (loss) , net of taxes |
|
|
(512) |
|
|
(459) |
|
|
(717) |
|
|
(1,898) |
|
|
759 |
Total comprehensive income (loss) for the period, net of taxes |
|
(571) |
|
|
(511) |
|
|
(1,821) |
|
|
(5,537) |
|
|
(4,246) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss) attributable to: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The owners of the parent |
|
|
(571) |
|
|
(511) |
|
|
(1,821) |
|
|
(5,537) |
|
|
(4,193) |
Non-controlling interest |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(53) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated statements of financial position (Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
30 September |
|
|
31 December |
(in thousand euros) |
|
|
2016 |
|
|
2015 |
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current assets |
|
|
|
|
|
|
|
Goodwill |
|
|
8,850 |
|
|
9,664 |
|
Intangible assets |
|
|
8,482 |
|
|
9,657 |
|
Property, plant & equipment |
|
|
42,124 |
|
|
38,400 |
|
Investments in joint ventures |
|
|
650 |
|
|
1,018 |
|
Deferred tax assets |
|
|
417 |
|
|
1,092 |
|
Other financial assets |
|
|
411 |
|
|
356 |
|
Total non-current assets |
|
|
60,934 |
|
|
60,187 |
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
Inventory |
|
|
6,215 |
|
|
5,387 |
|
Trade receivables |
|
|
23,143 |
|
|
22,843 |
|
Held to maturity investments |
|
|
- |
|
|
- |
|
Other current assets |
|
|
6,744 |
|
|
4,993 |
|
Cash and cash equivalents |
|
|
50,490 |
|
|
50,726 |
|
Total current assets |
|
|
86,592 |
|
|
83,949 |
|
|
|
|
|
|
|
|
Total assets |
|
|
147,526 |
|
|
144,136 |
|
|
|
|
|
|
|
|
Equity and liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
Share capital |
|
|
2,729 |
|
|
2,729 |
|
Share premium |
|
|
78,770 |
|
|
78,098 |
|
Consolidated reserves |
|
|
(2,224) |
|
|
1,407 |
|
Treasury shares |
|
|
- |
|
|
- |
|
Other comprehensive income |
|
|
(1,177) |
|
|
721 |
|
Equity attributable to the owners of the parent |
|
|
78,098 |
|
|
82,955 |
|
Non-controlling interest |
|
|
- |
|
|
- |
|
Total equity |
|
|
78,098 |
|
|
82,955 |
|
|
|
|
|
|
|
|
|
Non-current liabilities |
|
|
|
|
|
|
|
Loans & borrowings |
|
|
20,682 |
|
|
16,607 |
|
Deferred tax liabilities |
|
|
1,284 |
|
|
2,068 |
|
Deferred income |
|
|
- |
|
|
92 |
|
Other non-current liabilities |
|
|
2,374 |
|
|
2,244 |
|
Total non-current liabilities
|
|
|
24,340 |
|
|
21,011 |
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
Loans & borrowings |
|
|
5,734 |
|
|
4,482 |
|
Trade payables |
|
|
9,944 |
|
|
9,712 |
|
Tax payables |
|
|
489 |
|
|
255 |
|
Deferred income |
|
|
17,963 |
|
|
16,509 |
|
Other current liabilities |
|
|
10,958 |
|
|
9,212 |
|
Total current liabilities |
|
|
45,088 |
|
|
40,170 |
|
|
|
|
|
|
|
|
Total equity and liabilities |
|
|
147,526 |
|
|
144,136 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment P&L (Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In thousands euros |
|
|
Materialise
Software
|
|
|
Materialise
Medical
|
|
|
Materialise
Manufacturing
|
|
|
Total segments |
|
|
Adjustments &
eliminations
|
|
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three month period ended 30 September 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
|
7,632 |
|
|
9,537 |
|
|
11,567 |
|
|
28,736 |
|
|
- |
|
|
28,736 |
|
Segment EBITDA |
|
|
2,814 |
|
|
754 |
|
|
1,723 |
|
|
5,291 |
|
|
(2,816) |
|
|
2,475 |
|
Segment EBITDA % |
|
|
36.9% |
|
|
7.9% |
|
|
14.9% |
|
|
18.4% |
|
|
|
|
|
8.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three month period ended 30 September 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
|
6,303 |
|
|
9,123 |
|
|
10,457 |
|
|
25,883 |
|
|
- |
|
|
25,883 |
|
Segment EBITDA |
|
|
2,157 |
|
|
763 |
|
|
799 |
|
|
3,719 |
|
|
(2,724) |
|
|
995 |
|
Segment EBITDA % |
|
|
34.2% |
|
|
8.4% |
|
|
7.6% |
|
|
14.4% |
|
|
|
|
|
3.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the nine month period ended 30 September 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
|
22,044 |
|
|
27,849 |
|
|
33,080 |
|
|
82,973 |
|
|
27 |
|
|
83,000 |
|
Segment EBITDA |
|
|
7,181 |
|
|
238 |
|
|
2,410 |
|
|
9,829 |
|
|
(5,543) |
|
|
4,286 |
|
Segment EBITDA % |
|
|
32.6% |
|
|
0.9% |
|
|
7.3% |
|
|
11.8% |
|
|
|
|
|
5.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the nine month period ended 30 September 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
|
18,497 |
|
|
25,286 |
|
|
30,220 |
|
|
74,003 |
|
|
- |
|
|
74,003 |
|
Segment EBITDA |
|
|
6,387 |
|
|
(325) |
|
|
612 |
|
|
6,674 |
|
|
(6,618) |
|
|
56 |
|
Segment EBITDA % |
|
|
34.5% |
|
|
-1.3% |
|
|
2.0% |
|
|
9.0% |
|
|
|
|
|
0.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Net Profit/(Loss) to EBITDA and Adjusted EBITDA
(Unaudited) |
|
|
|
|
|
|
|
(in thousands) |
|
|
For the three months
ended
30 September
|
|
|
|
2016 |
|
|
2015 |
|
|
|
euros |
|
|
euros |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net profit / (loss) |
|
|
(52) |
|
|
(1,104) |
|
|
|
|
|
|
|
Income taxes |
|
|
191 |
|
|
296 |
Financial expenses |
|
|
181 |
|
|
373 |
Financial income |
|
|
(58) |
|
|
(524) |
Share in loss of a joint venture |
|
|
69 |
|
|
125 |
Depreciation & amortization |
|
|
2,144 |
|
|
1,829 |
|
|
|
|
|
|
|
EBITDA |
|
|
2,475 |
|
|
995 |
|
|
|
|
|
|
|
Non-cash stock-based compensation expenses (1) |
|
|
358 |
|
|
180 |
|
|
|
|
|
|
|
Adjusted EBITDA |
|
|
2,833 |
|
|
1,175 |
|
|
|
|
|
|
|
(1) Non-cash stock-based compensation expenses represent the cost of equity-settled
and cash-settled share-based payments to employees. |
|
|
Consolidated cash flow statements (Unaudited) |
|
|
|
|
|
|
|
(in thousand euros) |
|
|
For the nine month period
ended
30 September
|
|
|
|
|
2016 |
|
2015 |
|
|
|
|
euros |
|
euros |
Operating activities |
|
|
|
|
|
|
|
|
|
|
|
|
Net profit for the period |
|
|
-3,639 |
|
-5,005 |
|
|
|
|
|
|
|
Non-cash and operational adjustments |
|
|
|
|
|
|
Depreciation of property, plant & equipment |
|
|
4,669 |
|
3,816 |
|
Amortization of intangible assets |
|
|
1,425 |
|
1,061 |
|
Share-based payment expense |
|
|
718 |
|
652 |
|
Loss (gain) on disposal of property, plant & equipment |
|
|
-147 |
|
1 |
|
Fair value adjustment contingent liabilities |
|
|
54 |
|
- |
|
Movement in provisions and allowance for bad debt |
|
|
-2 |
|
162 |
|
Financial income |
|
|
-126 |
|
-2,523 |
|
Financial expense |
|
|
668 |
|
1,733 |
|
Impact of foreign currencies |
|
|
55 |
|
55 |
|
Share of loss of an associate or joint venture (equity method) |
|
|
368 |
|
248 |
|
Deferred tax expense (income) |
|
|
225 |
|
46 |
|
Income taxes |
|
|
587 |
|
575 |
|
Other |
|
|
7 |
|
- |
|
|
|
|
|
|
|
Working capital adjustments |
|
|
|
|
|
|
Increase in trade receivables and other receivables |
|
|
-2,394 |
|
-1,644 |
|
Decrease (Increase) in inventories |
|
|
-828 |
|
-973 |
|
Increase in trade payables and other payables |
|
|
3,203 |
|
3,955 |
|
|
|
|
|
|
|
|
|
|
|
4,843 |
|
2,159 |
|
|
|
|
|
|
|
|
Income tax paid |
|
|
-528 |
|
-530 |
|
|
|
|
|
|
|
Net cash flow from operating activities |
|
|
4,315 |
|
1,629 |
|
|
|
|
|
|
|
Investing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of property, plant & equipment |
|
|
-6,816 |
|
-5,918 |
|
Purchase of intangible assets |
|
|
-871 |
|
-1,019 |
|
Proceeds from the sale of property, plant & equipment, net |
|
|
192 |
|
13 |
|
Acquisition of subsidiary |
|
|
- |
|
-1,602 |
|
Investments in joint-ventures |
|
|
- |
|
-500 |
|
Proceeds from held to maturity investments |
|
|
- |
|
10,000 |
|
Interest received |
|
|
7 |
|
8 |
|
|
|
|
|
|
|
Net cash flow used in investing activities |
|
|
-7,488 |
|
982 |
|
|
|
|
|
|
|
Financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from loans & borrowings and convertible debt |
|
|
7,004 |
|
324 |
|
Repayment of loans & borrowings |
|
|
-2,116 |
|
-3,889 |
|
Repayment of finance leases |
|
|
-1,293 |
|
-1,108 |
|
Purchase of non-controlling interest |
|
|
- |
|
-1,377 |
|
Capital increase in parent company |
|
|
- |
|
580 |
|
Interest paid |
|
|
-406 |
|
-399 |
|
Other financial income / (expense) |
|
|
-7 |
|
-34 |
|
|
|
|
|
|
|
Net cash flow from financing activities |
|
|
3,182 |
|
-5,903 |
|
|
|
|
|
|
|
Net increase of cash and cash equivalents |
|
|
9 |
|
-3,292 |
|
Cash and cash equivalents at beginning of period |
|
|
50,726 |
|
51,019 |
|
Exchange rate differences on cash & cash equivalents |
|
|
-245 |
|
1,007 |
|
Cash & cash equivalents at end of period |
|
|
50,490 |
|
48,734 |
|
|
|
|
|
|
|
Investors:
LHA
Harriet Fried/Jody Burfening
212-838-3777
hfried@lhai.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20161109005136/en/